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The molecular events underlying the inhibition of exocytosis by tetanus toxin were investigated in permeabilized adrenal chromaffin cells. We found 
that replacement of amino acid residues within the putative zinc binding domain of the tetanus toxin light chain such as of histidine (position 233) 
by cysteine or valine, or of glutamate (position 234) by glutamine completely abolished the effect of the light chains on Ca2’ induced catecholamine 
release. Dipicolinic acid, a strong chelating agent for zinc, also prevented the effect of the tetanus toxin light chain. Zn*+ and, less potently Cu*’ 
and Ni2+, but not Cd2+ and Co2’, restored the activity of the neurotoxin. These data show that zinc and the putative zinc binding domain constitute 
the active site of the tetanus toxin light chain. Neither captopril, an inhibitor of synaptobrevin cleavage nor peptides spanning the site of 
synaptobrevins cleaved by the tetanus toxin in neurons, prevented the inhibition of Ca2+ induced catecholamine release by the tetanus toxin light 
chain. This suggests that synaptobrevins are not a major target of tetanus toxin in adrenal chromatBn cells. 
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1. INTRODUCTION 
Synapses are sites of neuronal communication spe- 
cialized on the regulated release of transmitters that 
excite or inhibit the target cells. Within the nerve termi- 
nals, transmitters are stored in synaptic vesicles which 
fuse with the plasma membrane and release their con- 
tents in response to an increase of intracellular calcium 
triggered by an invading action potential. Synaptic ves- 
icle membranes contain a number of proteins which 
have been cloned and characterized in the recent years 
[1,2]. Some of these proteins interact with proteins at 
the plasma membrane and have been implicated in 
docking and fusion of synaptic vesicles. For example 
synaptophysin, which like its congener synaptoporin 
[3], is thought to be involved in the formation of the 
initial pore [4] and interacts with physophilin at the 
presynaptic membrane [5]. Similarly synaptotagmin, 
which is thought to act as a calcium receptor during 
exocytosis [6], binds to neurexins and syntaxins, re- 
cently detected new families of plasma membrane pro- 
teins [7-91. Synaptobrevin, the most conserved synaptic 
vesicle membrane protein [lo], apparenly attaches to 
syntaxins via a complex that includes cytoplasmic pro- 
teins [ll]. 
Recent functional investigations upport the idea that 
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the synaptic vesicle membrane proteins mentioned 
above participate directly in the exocytotic process: an- 
tibodies to synaptophysin and peptides corresponding 
to the cytoplasmic domain of synaptotagmin inhibit 
exocytosis [12-151. Blockade of transmitter release by 
tetanus toxin is paralleled by the cleavage of synapto- 
brevin [16-181. Tetanus toxin, similar to botulinum A 
toxin and related neurotoxins, consist of a heavy and a 
light chain linked by a disulfide bond [19]. After entry 
of the neurotoxins into the nerve terminals the light 
chain blocks transmitter elease in Aplysia neurons and 
mammalian nerve terminals [20-251. 
The key observation that the light chains of tetanus 
and botulinum A toxin harbor the active domain has 
initially been made with permeabilized adrenal chro- 
maffin cells [2632] which, unlike exocrine cells [33], 
have the intracellular target of the neurotoxins. The 
light chains of the neurotoxins bind zinc and contain the 
HELIH motif shared with a variety of zinc peptidases 
[19,34-381 suggesting that zinc and the metal binding 
motif are essential for the inhibition of exocytosis by the 
neurotoxins. 
In the present study we directly addressed this ques- 
tion and analyzed whether mutation of the zinc binding 
motif of the tetanus toxin light chain affects its function 
in adrenal chromaffin cells. We also investigated the 
role of zinc and other ions as components of the active 
site of the tetanus toxin light chain. Finally we examined 
whether substances, which prevent cleavage of synap- 
tobrevin and blockade of neurotransmission by tetanus 
toxin in neurons, abolish also the effect of the neuro- 
toxin in the endocrine adrenal chomaffin cell. 
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2. EXPERIM~~AL 
2. I. Materials 
Tetanus toxin light chain, prepared as described recently [39-41] 
was a generous gift from U. Weller (Institut fiir Mediinische Mikro- 
biologie, Universitiit Mainz). The expression of recombinant light 
chains of tetanus toxin in E. cd strain Ml5 using a newly synthesized 
gene 1421 encoding the entire light chain with six C-terminally added 
H-residues will be published elsewhere (H. Niemann et al., unpub- 
lished). The protein was purified from the bacterial ysates on a Ni- 
agarose column. Mutants were generated by replacement of a SnaBI- 
FphI restriction fragment [42] with suitable synthetic oligonucleotides. 
Recombinant light chain (wild-type; WT), recombinants in which his- 
tidine (position 233) was replaced by cysteine or valine (mutants 
Ht33C, or H233V) and the recombinant E234Q, in which glutamate 
(position 234) was substituted by glutamine, were kindly provided by 
H. Niemann, Bundesforschungsanstalt fur Viruskrankheiten der 
Tiere, Tubingen, Germany. 
The peptides QFET and ASQFETS were kindly prepared by Mrs. 
J. Neckermann and Dr. T. Ruppert (Ulm) by solid phase synthesis 
using a automatic synthesizer (43 lA, Applied Biosystems, Foster City, 
CA, USA) employing F-mot chemistry. The product was detached 
from the resin with TFA, and analyzed by HPLC on a Pep-S 5 pm 
column (PharmacialLKB, Freiburg, Germany). The peptides were 
characterized by Edman sequencing on a model 473A sequencer (Ap- 
plied Biosystems, Foster City, CA, USA). Peptides 1 (DALQAGAS- 
VFESSAAKLKRK) and 2 (DALQAGASQFETSAAKLKRK) were 
generous gifts from H. Niemann, Tiibingen, Germany. 
3-Mercapto-2-methylpropionyl-L-proline (captopril) was kindly 
provided by B~stol-Myers Squibb, M~nchen. Fungizone, penicillin, 
streptomycin, DMEM, FCS were purchased from Seromed, Berlin; 
collagenase (cl. histolyticmn) from Serva, Heidelberg; cytosine arabi- 
nosid from Sigma, Mtinchen, and [3H]noradrenaline from Amersham, 
Braunschweig. All the other chemicals were of analytical grade. 
2.2. Methods 
2.2.1. Cell cultures 
Fresh bovine adrenals were rinsed free of blood by vascular perfu- 
sion with ice-cold medium I (in mM: 150 NaCI, 5 KCl, 10 glucose, 10 
HEPES pH 7.4) supplemented with 0.25 @ml fungizone, 50 IU pen- 
icillin and 50 fig/ml streptomycin. Subsequently medium I was supple- 
mented with 0.05% collagenase (cl. histolyticum) and 0.5% BSA fol- 
lowed by incubation of the adrenals for one hour at 37°C. Then the 
medullae were removed, cut into small pieces and incubated with 
collagenase for a further hour. The cell suspension was filtered 
through a nylon mesh (250 pm) and washed 3 times with medium I
supplemented with 2% BSA. The cells were resuspended in culture 
medium (DMEM) containing 10% fetal calf serum and 5 pm cytosine 
arabinoside. They were plated on precoated (ZO&ml rat tail collagen) 
wells (diameter 11.3 mm) at a density of 3 x l@ cells/well. The cell 
cultures were maintained in culture for 2-10 days at 37°C with 5% 
co> 
2.2.2. Assay for exocytosis 
Adrenal chromaffin cells were incubated for one hour with [‘Hjnor- 
adrenaline (1.3 ,uCi/ml) in serum-free culture medium (DMEM) sup- 
plemented with 1 mM ascorbic acid. Ca” was removed from the 
cultures by 3 washes with medium II (in mM: 140 NaCl, 4.7 KCI, 
1.2 KH,PQ,, 1.2 MgSO,, 0.5 ascorbic acid, 15 PIPES pH 7.2) supple- 
mented with 11 mM glucose, followed by washes with medium III (in 
mM: 150 NaCl, 1 EGTA, 10 PIPES pH 7.2) and medium IV (in mM: 
150 potassium glutamate, 0.5 EGTA, S NTA, 10 PIPES, pH 7.2). The 
osmolarity of the media was maintained between 300 and 310 
mOs-mollkg. 
The cells were stabilized with SLO (63 HW150 ~1) as described 
previously [33,43] in potassium glutamate medium (in mM: 150 potas- 
sium glutamate, 0.5 EGTA, 5 EDTA, 2 Mgz’-ATP, 7.67 magnesium 
acetate to obtain a free Mg’+ concentration of 1, 10 PIPES, pH 7.2), 
supplemented with 0.1% BSA and 1 mM dithiothreitol as a reducing 
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agent for 2 min at 30°C. The medium was then replaced by a fresh one 
containing the neurotoxins and/or the chemicals to be tested and 
incubated for 25 min at 30°C. Then the cells were stimulated for 
15 min at 30°C with potassium glutamate medium containing 30 PM 
free Ca2+. Basal release was determined in the same medium with no 
Ca2+ added. Free Ca” concentrations were calculated and controlled 
with a Ca” specific electrode as described 1441. 
[3H~oradren~ine released into the supematant and remaining in 
the cells (after lysis with 0.2% SDS) was determined. Percentage of 
[3H]noradrenaline r leased was calculated using catecholamine con- 
tent of the lysate plus released catecholamines as 100%. The values 
given are means + SD. of 3 wells. 
3. RESULTS AND DISCUSSION 
In order to find out whether the HELIH motif (resi- 
dues 233-237 in the tetanus toxin light chain; TetxL), 
shared by clostridial neurotoxins and zinc peptidases 
[19,38] is involved in the function of tetanus toxin, we 
first analyzed whether mutational modification of the 
motif affects the activity of TeTxL. We found that the 
recombinant wild type TeTxL @VT) at 100 nM almost 
completely inhibited Ca2’ induced catecholamine re- 
lease from permeabilized chromaffin cells (Fig. 1). By 
contrast, using the same concentrations of recominant 
light chains in which histidine233 was replaced by cyste- 
ine or valine (mutants H233C and H*““v> or r~ombinant 
E234Q in which glutamate234 was substituted by glutam- 
ine, no inhibition of calcium induced catecholamine re- 
lease was observed (Fig. 1). Recently it was found that 
also chemical modification of histidines of the tetanus 
toxin abolishes the effect of tetanus toxin on transmitter 
release in Aply.siu neurons [lc;l. In metalfoendoproteases 
30 1 
O- 
CWlWd WT PC Hz% E2% 
Fig. 1. Wild-type TetxL but not mutants (H233C, H233V, E’“Q) of 
TetxL inhibit catecholamine release. After permeabilization the cells 
were incubated for 25 mm at 30°C with potassium glutamate medium 
(control), 100 nM recombinant etanus toxin Iight chain (wild-type; 
WT) or 100 nM mutated recombinant etanus toxin light chains 
(H233C, H233V, E234Q) in potassium glutamate medium (see section 
2.2). Then the cells were incubated for 15 min at 30°C with potassium 
glutamate medium containing 30 PM free Ca” (tilled bars) or no Ca*’ 
(open bars) and the percentage of [3H]noradrenaline r leased into the 
su~mat~t was determined. Note the inhibition of Caz+ induced 
catecholamine release by wild-type TetxL whereas mutants bearing 
point mutations in the HELIH motif (Hu3C, H233V, Er”Q) were inac- 
tive. Data are means f SD. of 3 wells. One out of 7 experiments with 
similar results. 
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Fig. 2. EDTA has no effect on the activity of the tetanus toxin light 
chain. Natural TetxL was first preincubated for 30 min at 30°C in 
potassium glutamate medium containing 5 or 10 mM EDTA and then 
added to the permeabilized chromaftin cells. After a further incuba- 
tion period of 25 min (see section 2.2 and Fig. 1) the release of 
[‘Hlnoradrenaline was determined in the absence or presence of 30pM 
free Ca*+. Compared to the control (presence of EDTA, no TetxL) 
release of [‘Hlnoradrenaline was almost completely inhibited by TextL 
and not affected by the different EDTA concentrations. Data are 
means + S.D. of 3 wells. Three similar experiments with different cell 
preparations. 
the first histidine within the HELIH motif interacts with 
the zinc ion whereas the adjacent glutamate plays a 
catalytic role [45,46]. Our mutational analysis directly 
shows the functional importance of these aminoacids in 
the HELIH motif for the inhibition of exocytosis by the 
tetanus toxin light chain in adrenal chromaffin cells. 
Zinc is bound to the histidine rich metal binding site 
within the TeTxL [16,35]. Removal of zinc from tetanus 
toxin at neutral pH by chelating agents such as EDTA 
COllWd TeTxL TeTxL 
DPA 
TeTxL DPA 
DPA 
lOO,,M 2n2+ 
Fig. 3. Effect of Zn2’ on the activity of TetxL. Natural TetxL was first 
preincubated at 30°C in potassium glutamate medium with or without 
100 ,BM dipicolinic acid (DPA) followed by 100 PM Zn2’ and then 
added to the permeabilized chromaffin cells. After a further incuba- 
tion period of 25 min (see section 2.2) the release of [‘H]noradrenaline 
was determined in the absence or presence of 30 pM free Ca”. DPA 
abolished the effect of TetxL and 100 PM Zn” restored the activity 
of TetxL. Data are means f S.D. of 3 wells (16 similar experiments). 
The release determined in the presence of DPA alone was not signifi- 
CCNWOI TeTxL 
$2’ xcL 
TeTxL 
DPA %pTAxL TDepTAyL 
a=+ G”=+ Ni*+ CZ+ Cd’+ 
Fig. 5. Effect of different divalent cations on the activity of TetxL. 
Preincubation of 100 nM natural TetxL with 100 PM DPA and 
100 PM Zn2+ yielded a fully active light chain. TetxL was only partly 
active upon addition of 100 PM Cu” and less activity was observed 
with 100 /IM Ni’+, Co2’ and Cd*‘. Data are means f S.D. of 3 wells 
(9 similar experiments). The release observed in the presence of Zn2’ 
Cu2’ and Ni2+ was significantly different from that in the controls 
(Scheffe test). DPA alone does not significantly change catecholamine 
cantly different from the controls (Scheffe test). release (see Fig. 3). 
Fig. 4. Effect of different concentrations of Zn2+ on the activity of 
TetxL. Natural TetxL (100 nM) were preincubated with 100,~M DPA 
followed by 1,lO or 1OOpM Zn” and then added to the permeabilized 
chromaffin cells. After a further incubation period of 25 min (see 
section 2.2) catecholamine release was determined in the absence or 
presence of 30 ,uM free Ca” (see section 2.2). While 100 PM Zn2’ 
completely restored the activity of TetxL, 10 PM Zn2+ was only partly 
effective. Data are means + SD. of 3 wells (3 similar experiments). 
requires long incubation and elevated temperature (e.g. 
one hour at 37’C) [16,47]. In our attempts to remove 
zinc with the aim to inhibit the activity of the TeTxL we 
used a variety of chelators. Treatment of light chains 
with different concentrations of EDTA, which binds 
zinc with high affiity, at room temperature, at 30°C 
and different periods of incubation did not result in an 
inactivation of TeTxL (Fig. 2). Similarly, NTA, 2,2’- 
dipyridil, l,lO-phenanthroline, diethyldithiocarbamate 
and phosphoramidon, when tested at concentrations 
not affecting calcium induced catecholamine release 
from the cells, were without effect (not shown). Only 
177 
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Fig. 6. Captopril has no effect on the activity of TeTxL. Natural 
TeTxL (100 nM) in the absence or presence of 0.1 or 1 mM captopril 
were added to permeabilized chromaffin cells followed by 25 min of 
incubation at 30°C. Then the release of catecholamines was deter- 
mined in the presence and absence of 30 PM calcium. Captopril, a 
potent inhibitor of zinc containing peptidases and cleavage of synap- 
tobrevin by tetanus toxin had no effect on the inhibitory action of 
TetxL. Captopril alone had no effect on the Ca2+ induced catecholam- 
ine release by permeabilized chromaffin cells. Data are means + SD. 
of 3 wells (4 similar experiments). 
dipicolinic acid (DPA), a chelating agent with high af- 
finity for zinc and low athnity for calcium and magne- 
sium [48], effectively blocked the activity of TeTxL 
already within 5 min at 30°C. This blockade was revers- 
ible since subsequent addition of 100 PM zinc restored 
the activity of TeTxL (Fig. 3). We determined the 
amounts of zinc in the TeTxL preparation (Dayanithi 
et al., unpublished) in the permeabilization medium 
containing 5 mM EDTA and 0.5 mM EGTA (see sec- 
tion 2.2) by atomic absorption spectroscopy and found 
that it contained 0.68 atoms zinc per mole TeTxL. Fol- 
lowing treatment with 100 ,uM DPA we measured 0.05 
atoms zinc per mole TeTxL. This indicates that zinc is 
effectively removed from TeTxL by DPA, a chelating 
TeTxL TeTxL 
Pep1 
TeTxL 
ASGFETS 
agent which blocks the effect of TeTxL on catecholam- 
ine release. 
In a further series of experiments we added different 
concentrations of zinc and found that 1 PM zinc was 
ineffective, but 10 ,uM partly and 100 ,uM completely 
restored the toxins ability to block exocytosis (Fig. 4). 
In order to find out whether other divalent cations can 
replace zinc at the toxins’ catalytic site, we added Cd*+ 
or Co’+ and found that these metals were inactive while 
Cu2+ and N?+ could restore the activity of TeTxL to a 
certain extent (Fig. 5). Interestingly, also in recent bind- 
ing studies Cu2+ was able to displace completely radio- 
active zinc from tetanus toxin [35] but Ni2+, Co” and 
Cd’+ were less effective. Thus our funtional data are in 
accordance with the properties of zinc binding by teta- 
nus toxin. Furthermore they show that zinc, with re- 
spect o function, can only be replaced by Cu2+ and Ni2+ 
as a ligand of the HELIH motif forming the catalytic 
site of the tetanus toxin light chain. 
Cleavage of synaptobrevin, an integral membrane 
protein of synaptic vesicles, by tetanus toxin has been 
related to the inhibition of transmitter elease in neu- 
rons [l&18]. In order to find out whether synapto- 
brevin could be a target of TeTxL in chromaffin cells 
we investigated the effect of substances that block syn- 
aptobrevin cleavage and prevent tetanus toxin action in 
neurons. Captopril, which inhibits the zinc peptidase 
angiotensin converting enzyme in low (nanomolar) con- 
centrations [49] has been shown to block cleavage of 
synaptobrevin by tetanus toxin when applied in milli- 
molar concentrations [17]. However, even at these high 
concentrations captopril did not affect the function of 
TeTxL in permeabilized chromaffin cells (Fig. 6). We 
also employed peptides, corresponding in sequence to 
the cleavage site of synaptobrevin 2, which were found 
to block the tetanus toxin light chain action within 
Aplysia neurons and the cleavage of synaptobrevin [ 171. 
TeTxL TeTxL 
Pep2 
Fig. 7. (a and b) Synthetic peptides corresponding to motifs present in synaptobrevin 1 and 2 have no effect on the activity of TeTxL. Natural 
TeTxL (100 nM) and 100 PM peptides were added to permeabilized chromaffin cells followed by 25 mm of incubation at 30% Then the release 
of catecholamines was determined in the presence and absence of 30 PM calcium. The inhibition of calcium induced catecholamine release by 
100 PM TetxL was not affected by the presence of 100 PM peptide 1 (DALQAGASVFESSAAKLKRK), ASQFETS (a), peptide 2 
(DALQAGASQFETSAAKLKRK) or QFET (b). The peptides alone had no effect on the Ca *+ induced catecholamine release (not shown). Data 
are means f S.D. of 3 wells (8 similar experiments). 
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However, these peptides neither alone nor in the pres- 
ence of TeTxL modified calcium-induced catecholam- 
ine release from chromatIin cells (Fig. 7a,b). In addition 
similar peptides derived from synaptobrevin 1 were in- 
active (Fig. 7b). The reason for the ineffectivity of cap- 
topril and the peptides is at present not clear. Posssibly 
the interaction of the tetanus toxin light chain with its 
target in chromaffin cells is less sensitive to the inhib- 
itors used here. The absence of synaptobrevin from 
chromaffin vesicles, the storage organelles for catechol- 
amines in chroma0in cells [50,51] also provides evi- 
dence for a separate target. 
Recently it was reported, that tetanus toxin activates 
transglutaminase which then modifies synapsin 1 
[52,53]. This process would impair the recruitment of 
synaptic vesicles for exocytosis in nerve terminals. Acti- 
vation of transglutaminase by tetanus toxin depends on 
calcium [52] and some transglutaminases can be inhib- 
ited by zinc [54] and/or activated by proteolysis [55]. It 
is unclear at present whether transglutaminase(s) of
chromaffin cells have similar properties and whether 
they may serve as targets of TeTxL in chromaffin cells. 
Taken together our study shows that the HELIH 
motif in the tetanus toxin light chain together with 
bound zinc constitutes the catalytic site responsible for 
the inhibition of catecholamine release from adrenal 
chromaffin cells and that synaptobrevin cleavage does 
not appear to be the mechanism of tetanus toxin action 
in chromaffin cells. 
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